Processa Pharmaceuticals
Processa is a clinical-stage pharmaceutical company developing a BTK inhibitor and legacy assets including PCS499 and PCS12852.
424B4Sep 22Latest SEC filing
Aug 4Latest story
Sign inSign inProcessa is a clinical-stage pharmaceutical company developing a BTK inhibitor and legacy assets including PCS499 and PCS12852.